Loading...
AOA | FCEF | AOA / FCEF | |
Gain YTD | 13.800 | 7.204 | 192% |
Net Assets | 1.8B | 26.1M | 6,885% |
Total Expense Ratio | 0.15 | 2.20 | 7% |
Turnover | 5.00 | 16.00 | 31% |
Yield | 1.93 | 7.40 | 26% |
Fund Existence | 15 years | 7 years | - |
AOA | FCEF | |
---|---|---|
RSI ODDS (%) | 3 days ago70% | 3 days ago66% |
Stochastic ODDS (%) | 3 days ago62% | 3 days ago62% |
Momentum ODDS (%) | 6 days ago82% | 6 days ago78% |
MACD ODDS (%) | 3 days ago78% | 7 days ago81% |
TrendWeek ODDS (%) | 3 days ago73% | 3 days ago73% |
TrendMonth ODDS (%) | 3 days ago77% | 3 days ago83% |
Advances ODDS (%) | 3 days ago77% | 3 days ago85% |
Declines ODDS (%) | 6 days ago74% | 5 days ago76% |
BollingerBands ODDS (%) | N/A | 3 days ago66% |
Aroon ODDS (%) | 3 days ago75% | 3 days ago82% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PGWAX | 66.01 | 0.45 | +0.69% |
Virtus Silvant Focused Growth A | |||
FSGAX | 39.11 | 0.20 | +0.51% |
Franklin Small-Mid Cap Growth Adv | |||
LASGX | 12.13 | 0.04 | +0.33% |
Lord Abbett International Growth R4 | |||
JHARX | 9.75 | -0.03 | -0.31% |
JHancock Multi-Asset Absolute Return R2 | |||
RYOIX | 67.34 | -0.54 | -0.80% |
Rydex Biotechnology Inv |